The clinical effectiveness and costeffectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: A systematic review
N. Fleeman, C. Martin Saborido, K. Payne, A. Boland, R. Dickson, Y. Dundar, A. Fernández Santander, S. Howell, W. Newman, J. Oyee, T. Walley
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The clinical effectiveness and costeffectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: A systematic review'. Together they form a unique fingerprint.